141 related articles for article (PubMed ID: 37956540)
1. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
[TBL] [Abstract][Full Text] [Related]
2. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract][Full Text] [Related]
3. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
[TBL] [Abstract][Full Text] [Related]
4. Vitreoretinal Lymphoma.
Sobolewska B; Chee SP; Zaguia F; Goldstein DA; Smith JR; Fend F; Mochizuki M; Zierhut M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439078
[TBL] [Abstract][Full Text] [Related]
5. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.
Diaconita V; Rihani H; Mares V; Nehemy MB; Bakri SJ; Pulido JS
Int J Retina Vitreous; 2019; 5():19. PubMed ID: 31452937
[TBL] [Abstract][Full Text] [Related]
6. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
8. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement.
Lai J; Chen K; Shi HM; Zhuang L; Zhou X; Xiao JJ; Li Y; Chen BB; Wang QP
Int J Ophthalmol; 2019; 12(6):1001-1007. PubMed ID: 31236360
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Imaging of Vitreo-Retinal Lymphoma: A Comprehensive Review.
Rissotto F; Cicinelli MV; Servillo A; Berni A; Menean M; Bianco L; Antropoli A; Bandello F; Miserocchi E; Marchese A
Ocul Immunol Inflamm; 2024 Mar; ():1-7. PubMed ID: 38436928
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.
Takase H; Arai A; Iwasaki Y; Imai A; Nagao T; Kawagishi M; Ishida T; Mochizuki M
Prog Retin Eye Res; 2022 Sep; 90():101053. PubMed ID: 35210172
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
12. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
13. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
14. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
15. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular Involvement.
Zhou X; Tian S; Zhou X; Shi H; Li Y; Xiao J; Chen K; Chen B; Xu G; Wang Q
Cancer Manag Res; 2022; 14():1007-1018. PubMed ID: 35283643
[TBL] [Abstract][Full Text] [Related]
17. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
19. Eye involvement in primary central nervous system lymphoma.
Farrall AL; Smith JR
Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
[TBL] [Abstract][Full Text] [Related]
20. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]